Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06159777 · ClinicalTrials.gov registry record · Phase 4

Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery

A Phase 4 study of Constipation and Surgical Procedure, Unspecified, sponsored by University Hospitals Cleveland Medical Center.

Recruiting
Registry status
Phase 4
Development phase
74
Enrollment target
1
Study location

NCT06159777: Recruiting Phase 4 study of Constipation and Surgical Procedure, Unspecified, sponsored by University Hospitals Cleveland Medical Center.

NCT06159777 is a Phase 4 study of Constipation and Surgical Procedure, Unspecified that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 74 participants, below the 204-participant average among 54 other Constipation trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06159777, a Phase 4 study of Constipation and Surgical Procedure, Unspecified, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.

RECRUITING
Registry status
Phase 4
Development phase
74 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test the use of a laxative before surgery in women having surgery to fix pelvic prolapse that do not have constipation. The main question it aims to answer is: Does use of a laxative before surgery lessen the discomfort of bowel movements after surgery? Participants will be asked to complete questionnaires before and after surgery. Researchers will compare using the laxative before and after surgery versus only after surgery to see if there is less discomfort with bowel movements after surgery.

Primary Outcome

Patient assessment of constipation symptoms (PAC-SYM) is a validated 12-item questionnaire with reported average score 0-4.

Interventions

  • DRUG Polyethylene Glycol 3350

Study Locations (1)

Ohio

  • University Hospitals Cleveland Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2024-06-05
Est. Completion 2026-04-30
Phase Phase 4

What NCT06159777 shows while recruiting

NCT06159777 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 204-participant average among 54 other Constipation trials with a reported enrollment target (64% lower).

The record links to 3 conditions, with Constipation appearing as the primary indexed condition, and to 1 intervention - of which Polyethylene Glycol 3350 is the first listed.

NCT06159777 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06159777 about?

NCT06159777 is a clinical study titled "Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery". The goal of this clinical trial is to test the use of a laxative before surgery in women having surgery to fix pelvic prolapse that do not have constipation. The main question it aims to answer is: Does use of a laxative before surgery lessen the discomfort of bowel movements after surgery? Partici...

What is the current status of trial NCT06159777?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 74 participants. The study started on 2024-06-05. Estimated completion is 2026-04-30.

What conditions does trial NCT06159777 study?

This clinical trial studies the following conditions: Constipation, Surgical Procedure, Unspecified, Prolapse; Female.

What interventions are being tested in trial NCT06159777?

The interventions under investigation include: Polyethylene Glycol 3350 (DRUG).

Who is sponsoring clinical trial NCT06159777?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06159777 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Constipation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06159777's enrollment target sits among peer trials

74 25th of 54 higher than 30 of 54 other Constipation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Constipation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06159777, the US trial registry maintained by the National Library of Medicine. NCT06159777 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.